Tervo Raymond C, Azuma Scott, Fogas Bruce, Fiechtner Helen
Department of Pediatrics, University of Minnesota, Minneapolis, USA.
Dev Med Child Neurol. 2002 Jun;44(6):383-90. doi: 10.1017/s0012162201002250.
The purpose of this study was to identify group differences in children with attention-deficit-hyperactivity disorder and motor dysfunction (ADHD-MD) and ADHD only, and to evaluate the medication responsiveness of ADHD-MD. Sixty-three children (49 males and 14 females; mean age 9 years 10 months, SD 2 years 10 months) underwent a triple blind, placebo-controlled crossover study evaluating two dose levels of methylphenidate (0.3 mg/kg and 0.5 mg/kg [DOSAGE ERROR CORRECTED], twice daily) and placebo. Forty-nine trials were completed. Nineteen were children with ADHD-MD, 44 had ADHD only. Behavior and functioning were assessed at home and at school. Treatment effects were assessed using the Abbreviated Symptom Questionnaire for Parents and Teachers. Children with ADHD-MD were more likely to have severe ADHD-combined type and other neurodevelopmental and behavioral problems. Both groups of children had a linear dose response to medication (placebo, low, high) and there was no evidence of a group by dose interaction or an overall group effect at home or school. The lack of group effect suggests that these children responded to medication like the other subgroups.
本研究的目的是确定患有注意力缺陷多动障碍合并运动功能障碍(ADHD-MD)的儿童与仅患有注意力缺陷多动障碍(ADHD)的儿童之间的组间差异,并评估ADHD-MD对药物的反应性。63名儿童(49名男性和14名女性;平均年龄9岁10个月,标准差2岁10个月)进行了一项三盲、安慰剂对照的交叉研究,评估两种剂量水平的哌甲酯(0.3mg/kg和0.5mg/kg[剂量已校正],每日两次)和安慰剂。共完成了49次试验。其中19名是患有ADHD-MD的儿童,44名仅患有ADHD。在家中和学校对行为和功能进行了评估。使用家长和教师简式症状问卷评估治疗效果。患有ADHD-MD的儿童更有可能患有重度ADHD合并型以及其他神经发育和行为问题。两组儿童对药物(安慰剂、低剂量、高剂量)均有线性剂量反应,且没有证据表明在家中或学校存在组与剂量的相互作用或总体组效应。缺乏组效应表明这些儿童对药物的反应与其他亚组相似。